Rifabutin
NDC product · U.S. Food and Drug Administration (openFDA) · United States
-
Product NDC
70518-4594 -
Package NDC
70518-4594-0 -
Package NDC
70518-4594-1 -
Application number
ANDA215041 -
SPL ID
5fd9b40e-0a4f-e132-e063-6394a90a9f46 -
SPL set ID
754d2d7f-f0db-4f89-8fcd-5e2ff52d5030 -
UNII
1W306TDA6S
What the source publishes
- Labeler
- REMEDYREPACK INC.
- Active ingredients
- Rifabutin
- Form
- CAPSULE
- Routes
- ORAL
- Administrative status
- present-in-source-snapshot
- Marketing status
- ANDA
- Product type
- HUMAN PRESCRIPTION DRUG
- Prescription
- Prescription or restricted
Names this record is found by
Complete source data
{
"name": "Rifabutin",
"splId": "5fd9b40e-0a4f-e132-e063-6394a90a9f46",
"labels": [
{
"setId": "754d2d7f-f0db-4f89-8fcd-5e2ff52d5030",
"labelUrl": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=754d2d7f-f0db-4f89-8fcd-5e2ff52d5030",
"labelPdfUrl": "https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=754d2d7f-f0db-4f89-8fcd-5e2ff52d5030"
}
],
"routes": [
"ORAL"
],
"labeler": "REMEDYREPACK INC.",
"finished": true,
"packaging": [
{
"sample": false,
"description": "60 CAPSULE in 1 BOTTLE, PLASTIC (70518-4594-0)",
"package_ndc": "70518-4594-0",
"identifierStatus": "well-formed",
"marketing_start_date": "20260324"
},
{
"sample": false,
"description": "50 POUCH in 1 BOX (70518-4594-1) / 1 CAPSULE in 1 POUCH (70518-4594-2)",
"package_ndc": "70518-4594-1",
"identifierStatus": "well-formed",
"marketing_start_date": "20260605"
}
],
"productId": "70518-4594_5fd9b40e-0a4f-e132-e063-6394a90a9f46",
"useDomain": "unknown",
"dosageForm": "CAPSULE",
"productNdc": "70518-4594",
"deaSchedule": null,
"genericName": "Rifabutin",
"productType": "HUMAN PRESCRIPTION DRUG",
"listingStatus": "present-in-source-snapshot",
"targetSpecies": [],
"approvalStatus": "not-established-by-ndc-listing",
"labelAssociation": "openFDA-harmonized-set-ids; not a product-level approval match",
"marketingEndDate": null,
"activeIngredients": [
{
"name": "RIFABUTIN",
"strength": "150 mg/1"
}
],
"applicationNumber": "ANDA215041",
"marketingCategory": "ANDA",
"stateRestrictions": {
"status": "not-collected",
"observations": []
},
"useDomainEvidence": {
"basis": "unreviewed",
"field": null,
"value": null,
"version": 1,
"sourceId": "us.fda.ndc"
},
"marketingStartDate": "20260324",
"targetSpeciesStatus": "not-reported",
"prescriptionCategory": "prescription-or-restricted",
"harmonizedIdentifiers": {
"nui": [
"N0000175501",
"M0019113"
],
"unii": [
"1W306TDA6S"
],
"spl_set_id": [
"754d2d7f-f0db-4f89-8fcd-5e2ff52d5030"
],
"pharm_class_cs": [
"Rifamycins [CS]"
],
"pharm_class_epc": [
"Rifamycin Antimycobacterial [EPC]"
],
"manufacturer_name": [
"REMEDYREPACK INC."
]
},
"listingExpirationDate": "20271231"
}
Read this record from your own software
The same record, with every field and its provenance, is one request away. An API key is free and works immediately.
curl -G "https://api.medifontis.com/v1/drugs/record" \
-H "Authorization: Bearer $MEDIFONTIS_API_KEY" \
--data-urlencode "country=us" \
--data-urlencode "sourceId=us.fda.ndc" \
--data-urlencode "id=us:fda:ndc:70518-4594_5fd9b40e-0a4f-e132-e063-6394a90a9f46"